Connect with Industry
IMPORTANT NOTICE: Our office remains committed to providing our standard level of excellent service. At this time, due to the fluid situation of the coronavirus pandemic, we will do so virtually, rather than in-person, during our regular business hours. To reach the Office of Technology Commercialization, please call 202.687.7424 or email firstname.lastname@example.org and Jeremy Alexander at email@example.com . Someone will respond to you promptly.
More information on COVID-19 related agreements can be found on the following link: https://otc.georgetown.edu/covid19-contracts/
Office of Technology Commercialization (OTC) manages Georgetown University invention disclosures, patenting and licensing activities, research collaboration agreements, material transfer agreements, confidentiality agreements, data use agreements, copyright and intellectual property agreements between the University and faculty, engagement of Georgetown University in the founding of startup companies, and assistance to University entrepreneurs in starting their own companies. If you believe that you have an invention, it is critical that you disclose the invention to OTC immediately, and prior to any publication or public presentation of the invention.
- About Us
- For Georgetown Inventors – Reporting an invention and other resources
- Industry Collaboration Opportunities for Georgetown Principal Investigators
- For Industry – Technology Licensing Opportunities
- Startup Guidance – For Georgetown Inventors and Entrepreneurs
- Events – List of events we host throughout the year
Top Stories From OTC
The Georgetown University Medical Center (GUMC) Office of the Dean for Research is proud to present the Dean’s Seminar Series. For more information on upcoming speakers, times and dates please visit the following link: https://biomedicalresearch.georgetown.edu/seminar-series/
Upcoming I2Is and Events:
Wednesday, September 30, 2020 12:00 pm – 1:30 pm – Virtual Zoom Event: “The Importance of Data in Patent Applications – From Filing Complete Provisional Applications to Addressing Rejections at the USPTO” presented by: Neil P. Shull, Ph.D. (Medler Ferro, Woodhouse & Mills)
In our monthly I2I (Invention to Innovation) event, OTC had the pleasure of hosting George Likourezos, J.D. and Dr. Carmella L. Stephens, Ph.D., J.D. from Carter, Deluca, & Farrell LLP. Georgetown University faculty and staff had the opportunity to learn more about IP protection for AI-implemented Life Sciences inventions and how University Entrepreneurs can prepare for commercialization of their technologies.
“Speed dating” for Innovation: OTC hosted an event where researchers and entrepreneurs with ideas had the opportunity to network with investors looking for ideas, enabling them to meet a large number of potential partners in a short amount of time
Research and Engagement
A Fast and Accurate COVID-19 Test: Georgetown University researchers have engineered a next generation pathogen detection system that has been shown to be extremely sensitive and specific and therefore to have extremely low false positive and false negative rates. It is as rapid or faster than other methods and can also be automated and used to test for multiple types of organisms simultaneously (“multiplexed”). We are kindly asking your support of this campaign that will allow researchers to use this groundbreaking technology to develop a high-fidelity rapid molecular test for detecting the COVID-19 virus. To support this campaign for a faster, more accurate COVID-19 test please visit the following link: https://www.givecampus.com. We appreciate your consideration of making a gift and sharing this important work with others who may also be interested in doing so.
2020 Technology Showcase will highlight technologies being developed at the NCI and the Frederick National Laboratory for Cancer Research (FNL). The showcase also includes presentations from experts to provide valuable insights and resources to start up companies. This Event will take place on Wednesday, September 9, 2020 at 12:00 pm. To register please visit following link: https://cbiit.webex.com
The DC Startup Showcase at The George Washington University is a collaboration of leading universities and research institutions based in Washington, DC. This virtual event will take place on September 29th from 2 – 5 PM EDT. To register for online presentation and networking please visit the following link: https://www.eventbrite.com/.
Pfizer’s Centers for Innovation (“CTI”) has opened its 2020 Call for Proposals requesting pre-proposals for innovative ideas for drug co-development from researchers at Georgetown University and other academic centers.
- Core research areas are Oncology, Inflammation and Immunology, Rare Diseases and Internal Medicine with strategic focus on the emerging areas of Senescence, Repeat Expansion Disorders and DNA Damage Response.
- Potential collaborations with Pfizer as part of CTI include collaborative and sponsored research agreements, venture/seed investment, and drug co-development.
- Only tech transfer and commercialization offices may submit proposals, therefore, Pfizer requires that you submit your non-confidential pre-proposal to Georgetown’s Office of Technology Commercialization (OTC) and OTC will submit the final pre-proposals to Pfizer.
- The deadline for submission of your pre-proposal to OTC is September 14th, 2020 (Preferred no later than September 8th, 2020). Please visit https://www.pfizercti.com/ particularly under “Submit a Proposal” for more information.
The Harrington Prize for Innovation in Medicine honors a physician-scientist (must hold MD or equivalent) for notable achievements in innovation, creativity, and potential for clinical application. The prize includes:
– An unrestricted $20,000 honorarium
– The Harrington Prize Lecture, delivered at the 2021 AAP/ASCI/APSA Joint Meeting
– Lecture at the 2021 Harrington Discovery Institute Symposium
– A personal essay, published in the Journal of Clinical Investigation
The deadline for nominations for the 2021 Harrington Prize is Friday, September 18, 2020. For more information and to submit a nomination, please visit the following link: HarringtonDiscovery.org/ThePrize (new window)
Pfizer Global Medical Grants Announces a New Education RFP in Non-Communicable Diseases. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Application Due date is July 20th, 2020. Link to full Request for Proposal: Management of Non-Communicable Diseases (NCD) for Health Care Providers (new window)-release.
New Women’s Venture Competition for Oncology Startups is being postponed due to Coronavirus from May 20th to a soon-to-be-announced summer 2020 date. More information can be found on the following link: https://aim-hiaccelerator.org/wvc/
Georgetown University (GU) continues to collaborate with George Washington University (GW) to help build the DC entrepreneurial community. We have been invited to join the “GWCAN” (More information can be found on the following link: https://giveandtakeinc.com/givitas-for-gwcan/). GW welcomes inventors, investors, new entrepreneurs and experienced entrepreneurs to explore the opportunities provided through the network. For more questions, contact the Office of Technology Commercialization, please call 202.687.7424 or email firstname.lastname@example.org.
9th Annual Deshpande Symposium (June 11-12, 2020) is a gathering of like-minded practitioners focused on accelerating innovation and entrepreneurship across the college and university environment. More information and conference agenda can be found on the following link: https://deshpandesymposium.org/agenda/
The Booz Allen Foundation has established a $1 million Innovation Fund to help nonprofits, entrepreneurs, thought leaders, innovators at colleges and universities, and startups and small businesses harness the power of data, technology, and diverse intellectual capital to improve COVID-19 relief efforts and make a difference. The Foundation is accepting applications from April 30 through June 5, 2020. Nonprofits can apply for grants of up to $100,000. Individuals, teams of individuals, and eligible for-profit organizations can apply for microgrants of up to $10,000. Certain eligibility requirements apply. For more information please see: BAF Innovation Fund
- Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial
- New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet
- Nilotinib Appears Safe in Parkinson’s Trial; Drug Thought to Allow Dopamine Replenishment
- Obese Mice Lose a Third of Their Fat Using a Natural Protein
- Researchers Find Inhibiting One Protein Destroys Toxic Clumps Seen in Parkinson’s Disease
- Other Stories Here
What is Technology Commercialization/ Technology Transfer?
Watch the Association of University Technology Managers (AUTM)’s site and video featuring the ins and outs of Technology Transfer and learn more about what is involved in its process.